Skip to main content
SpringerLink
Log in

News from ASH

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Deniz B, Morgan G, Schey S, Ishak J, Dale P, Shearer A, Caro JJ.Economic evalaution of lenalidomide combined with dexamethasone for the treatment of multiple myeloma in the UK. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2400, 7 Dec 2008. Available from: URL: http://www.hematology.org

  2. El Ouagari K, Tran K, Stephens J, Botteman M.Cost-effectiveness of adding imatinib to chemotherapy in adult patients with chromosom-positive acute lymphoblastic leukemia: a Canadian perspective. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2401, 7 Dec 2008. Available from: URL: http://www.hematology.org

  3. Deniz B, Facon T, Singer I, Micallef-Eynaud P, Joseph I, Shearer A, Caro JJ.Economic evaluation of thalidomide combined with melphalan and prednisone in previously untreated multiple myeloma in Scotland. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2395, 7 Dec 2008. Available from: URL: http://www.hematology.org

  4. Isogai PK, Cheung M, Mittmann N.Economic analysis of alemtuzumab in fludarabine-refractory and relapsed chronic lymphocytic leukemia in Canada. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2375, 7 Dec 2008. Available from: URL: http://www.hematology.org

  5. Feinberg B, Gilmore J, Haislip S, Franco CM, Gondesen T, Saleh MN.Pharmacoeconomic evaluation of hypomethylating agents used for the treatment of MDS. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 2380, 7 Dec 2008. Available from: URL: http://www.hematology.org

  6. Schwarzinger M, Baillot S, Beauchamp C, Maury S, Pautas C, Vekhoff A, Farhat H, Suarez F, Hemery F, Kuentz M, Cordonnier C.Cost-effectiveness of antifungal strategies in high-risk neutropenic patients. 50th Annual Meeting and Exposition of the American Society of Hematology: abstr. 1314, 6 Dec 2008. Available from: URL: http://www.hematology.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ASH. Pharmacoecon. Outcomes News 572, 6–7 (2009). https://doi.org/10.2165/00151234-200905720-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905720-00014

Keywords

Search

Navigation